Separation matrix and method of separation
The invention discloses a separation matrix comprising a plurality of multimodal ligands covalently coupled to a support, wherein said support is a membrane comprising nonwoven polymer fibers and wherein said ligands are capable of interacting with a target biomacromolecule. Further, the invention discloses separation methods using the separation matrix.
1 . A separation matrix comprising a plurality of multimodal ligands covalently coupled to a support, wherein said support is a membrane comprising nonwoven polymer fibers and wherein said ligands comprise multimodal cation exchange ligands and are capable of interacting with a target biomacromolecule, wherein said multimodal cation exchange ligands comprise copolymer chains comprising units derived from
a) a first monomer of structure CH 2 ═CH-L 4 -X 1 , where L 4 is a covalent bond or an alkyl ether or hydroxyl substituted alkyl ether chain comprising 2-6 carbon atoms, and X 1 is a sulfonate or phosphonate group and
b) a second non-charged vinyl amide monomer.
2 . The separation matrix of claim 1 , wherein said polymer fibers are cellulosic fibers.
3 . The separation matrix of claim 2 , wherein said polymer fibers are cellulose fibers are saponified or partially saponified cellulose acetate fibers.
4 . The separation matrix of claim 1 , wherein said polymer fibers are partially fused together, forming a plurality of fiber-fiber fusion points.
5 . The separation matrix of claim 1 , wherein said membrane comprises a plurality of nonwoven fiber layers and wherein said layers are partially fused together.
6 . The separation matrix of claim 1 , wherein said polymer fibers have diameters of 100-800 nm.
7 . The separation matrix of claim 1 , further comprising a grafted polymer coating covering said polymer fibers, wherein said multimodal ligands are covalently coupled to said grafted polymer coating, or optionally further comprising a plurality of grafted polymer molecules covalently tethered to said polymer fibers, wherein at least a portion of said multimodal ligands are covalently coupled to said grafted polymer molecules.
8 . The separation matrix of claim 7 , wherein said grafted polymer molecules are polyglycidol polymer molecules or polyglycidol copolymer molecules.
9 . The separation matrix of claim 7 , wherein said polymer fibers with said grafted polymer molecules or grafted polymer coating have diameters of 100-1000 nm.
10 . The separation matrix of claim 1 , having an average pore size of 200-800 nm.
11 . The separation matrix of claim 1 , having a bubblepoint pore size of 0.9-1.2 pm.
12 . The separation matrix of claim 1 , having a smallest pore size of 0.2-0.4 pm.
13 . The separation matrix of claim 1 , having a mean flow pore (MFP) size of 0.3-0.5 pm.
14 . The separation matrix of claim 1 , having a pore volume fraction of 50-90%.
15 . The separation matrix of claim 1 , having a ligand density of 100-2000 μmol ligands per g dry separation matrix.
16 . The separation matrix of claim 1 , wherein the pressure drop over the separation matrix is less than 1 MPa per mm bed height when an aqueous liquid phase of viscosity less than 1.2 mPas is passed through a thickness of 0.05 to 10 mm of the matrix at a flow rate of between 1 to 640 medium volumes per minute.
17 . The separation matrix of claim 1 , wherein the pressure drop over the separation matrix is less than 2 MPa when an aqueous liquid phase of viscosity less than 1.2 mPas is passed through a thickness of 0.05 to 10 mm of the matrix at a flow rate of between 1 to 640 medium volumes per minute.
18 . The separation matrix of claim 1 , wherein when an aqueous buffer of pH 5-8 is passed through the separation matrix at 0.4 s residence time, the pressure drop over the separation matrix changes by less than 0.07 MPa per mm bed height when the conductivity of the buffer is changed over an interval of 3-90 mS/cm.
19 . The separation matrix of claim 7 , wherein the grafted polymer molecules or grafted polymer coating comprise polymer molecules which are single-point covalently tethered to polymer nanofibers.
20 . The separation matrix of claim 7 , wherein the grafted polymer molecules or grafted polymer coating comprise branched polymer molecules.
21 . The separation matrix of claim 7 , wherein the grafted polymer molecules or grafted polymer coating comprise glycidol monomer residues.
22 . The separation matrix of claim 7 , wherein the grafted polymer molecules or grafted polymer coating comprise divinylsulfone monomer residues.
23 . The separation matrix of claim 1 , wherein said multimodal cation exchange ligands comprise ligands of structure SR 4 (COOH)—N(H)C(O)R 5 coupled to the support via the sulfur, wherein: R 4 is a C2-C6 alkylene group; and R 5 is a five- or six-membered, substituted or non-substituted, aromatic or aliphatic ring structure.
24 . The separation matrix of, wherein said multimodal cation exchange ligands comprise ligands of structure
coupled to the support via the sulfur.
25 . The separation matrix of claim 1 , wherein said multimodal cation exchange ligands comprise vinyl sulfonate-co-N-vinyl pyrrolidone copolymer chains.
26 . A method of recovering a purified biomacromolecule from a load fluid including one or more impurities, comprising the steps of:
a) passing the load fluid through the separation matrix of claim 1 ; and
b) recovering the purified biomacromolecule in the matrix effluent during the load cycle and optionally during any essentially isocratic wash.
27 . The method of claim 26 , wherein the biomacromolecule is a protein.
28 . A method of recovering a purified biomacromolecule from a load fluid including one or more impurities, comprising the steps of:
a) passing the load fluid through the separation matrix of claim 1 ;
b) optionally passing a wash fluid through the separation matrix;
c) passing an eluent through the separation matrix;
d) recovering the purified biomacromolecule in the eluent after passage through the separation matrix; and
e) passing a regeneration fluid through the separation matrix.
29 . The method of claim 28 , wherein the biomacromolecule is a protein.
30 . The method of claim 28 , wherein steps a)-e) are repeated at least 10 times.
31 . The method of claim 28 , wherein a total cycle time for the sequence of steps a)-e) is less than 5 minutes.
32 . The method of claim 26 , wherein said load fluid is an eluate from a preceding affinity chromatography step.
33 . The method of claim 32 , wherein the biomacromolecule is an immunoglobulin and said affinity chromatography step is a Protein A step.
34 . The method of claim 32 , wherein said affinity chromatography step is performed on a separation matrix comprising a plurality of affinity ligands covalently coupled to a support membrane comprising nonwoven polymer fibers.